Shu-Yuan Xiao

7PUBLICATIONS
9CO-AUTHORS
Molecular targetsCognitionIntensive careCardiology (incl. cardiovascular diseases)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 04, 2021
LRRK2 is a candidate prognostic biomarker for clear cell renal cell carcinoma.

Chunxiu Yang, Jingjing Pang, Jian Xu

|Mar 29, 2021
Thin-Section Chest CT Imaging of COVID-19 Pneumonia: A Comparison Between Patients with Mild and Severe Disease.

Minhua Yu, Dan Xu, Lan Lan

|Jun 13, 2020
Clinical outcomes of 402 patients with COVID-2019 from a single center in Wuhan, China.

Yingjie Wu, Wei Guo, Huan Liu

|May 28, 2020
Analysis of Mortality in Patients With COVID-19: Clinical and Laboratory Parameters.

Sufang Tian, Huan Liu, Meiyan Liao

|May 06, 2020
Hepatic involvement in COVID-19 patients: Pathology, pathogenesis, and clinical implications.

Yueying Li, Shu-Yuan Xiao

|Apr 16, 2020
Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies.

Sufang Tian, Yong Xiong, Huan Liu

Pageof 2